Understanding and Addressing Rejection of Personalized Breast Cancer Risk Information: Administrative Supplement Study
Completed · Phase 2
Conditions studied: Breast Cancer Female
In brief
The Understanding and Addressing Rejection of Personalized Cancer Risk Information study is a longitudinal study conducted to understand the nature of phenomenon of personalized cancer risk rejection in the context of mammography screening.
Key facts
- Study ID
- NCT06975085
- Run by
- University of Colorado, Denver
- People needed
- 781
- Starts
- 2025-04-16
- Expected to finish
- 2025-04-30
- Last updated by the study team
- 2026-08-03
Who can join
Age: 39 and older, up to 74. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Female sex
- Age 39-74 (i.e., people who are eligible for routine breast cancer screening and for whom guidelines recommend an informed, risk-based decision)
- English literacy
- Black or African American race
You may not qualify if…
- Prior diagnosis of
- breast cancer
- Ductal carcinoma in situ (DCIS)
- Lobular carcinoma in situ (LCIS)
- Known BRCA1/2 gene mutation
- Cowan syndrome
- Li-Fraumeni syndrome
- Having received previous chest radiation for treatment of Hodgkin's lymphoma.
Where it is running
- University of Colorado — Aurora, Colorado, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.